Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis

NCT00543426 is registered in ClinicalTrials.gov with Shanghai University of Traditional Chinese Medicine as lead sponsor.

NCT NCT00543426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00543426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
Lead sponsor
Shanghai University of Traditional Chinese Medicine
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2007
Completion date
June 30, 2009
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posthepatitic cirrhosis